The European cell sheet-based gene treatment market is experiencing significant development. This field is driven by an increasing need for innovative therapeutic solutions to address a wide range of genetic diseases. Effective clinical trials and regulatory authorizations are fueling market momentum. A key factor contributing to this situation … Read More